市場調査レポート
商品コード
1046434
血管閉鎖デバイスの世界市場 - 市場規模・シェア・動向分析:タイプ別、アクセス別、処置別、地域別の見通し、競合戦略、セグメント予測 (2030年まで)Global Vascular Closure Device Market Size, Share & Trends Analysis Report By Type, By Access, By Procedure, Regional Outlook, Competitive Strategies and Segment Forecast - 2030 |
血管閉鎖デバイスの世界市場 - 市場規模・シェア・動向分析:タイプ別、アクセス別、処置別、地域別の見通し、競合戦略、セグメント予測 (2030年まで) |
出版日: 2022年01月12日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 206 Pages
納期: 即日から翌営業日
|
世界の血管閉鎖デバイスの市場規模は、2021年の11億2,000万米ドルから、2030年までに15億8,000万米ドルに達し、CAGRで7.4%の成長が予測されています。心血管障害の世界的な負担は、世界中で年間約1,700万人の死亡を引き起こしています。心血管障害の患者数は、高齢者人口の増加に伴い、今後数年間で増加し続けると予想されます。
当レポートでは、世界の血管閉鎖デバイス市場について調査分析し、市場概要、促進要因・課題・機会、市場分析、主要企業などについて、体系的な情報を提供しています。
According to SPER Market Research, the global vascular closure device market was valued at USD 1.12 Bn in 2021 and estimated to reach USD 1.58 Bn by 2030 with a CAGR of 7.4%. The global burden of cardiovascular disorders causes around 17 Mn deaths per year across the globe. The number of patients with cardiovascular disorder will continue to grow as the geriatric population will increase in coming years.
The upsurge in COVID-19 infections across the world redirect the resources and professionals towards COVID relief thus, compromising with wound care services, and elective surgeries. The temporary denial is notified for all the non-emergent healthcare services. Enforcing of lockdowns, curfews and fear of getting infected restrict the patients to visit hospitals, clinics or OPDs.
By Type, By Access, By Procedure.
North America, Europe, APAC, Latin America, and the Middle East & Africa.
Companies Covered: Abbott, Cardinal Health, Medtronic, TZ Medical, Merit Medical Systems, Inc., Rex Medical, Vygon Company, Vasorum Ltd., Terumo Corporation, Cardiva Medical, Inc., Boston Scientific Corporation, Scion BioMedical, Morris Innovative, Inc., Vivasure Medical Ltd., Teleflex Incorporated, Tricol Biomedical, Transluminal Technologies, Meril Life Sciences Pvt. Ltd., Medas USA, Advanced Vascular Dynamics, Marine Polymer Technologies, Inc.
High occurrence of cardiovascular diseases across the world will render high growth of vascular closure devices market in the forecast period. Rising prevalence of obesity, increasing geriatric population is leading to higher number of patients suffering from cardiovascular diseases.
The high costs of vascular closure devices can hinder the growth of this market. Countries with poor reimbursement policies can pose significant challenge for the adaption of vascular closure devices. The risks associated with the use of vascular closure devices during surgical procedures such as infections, bleeding, device failures and thrombotic events can also restrict the estimated growth.
The vascular closure devices provide minimal invasion and reduces risk of excessive blood loss during the surgeries. The rising awareness of patients towards minimally invasive procedures will provide growth opportunities for this market. Rising number of hospitals and healthcare funding will also support the growth of vascular closure devices.
Based on product type, the market has been segmented into passive approximators, active approximators and external Hemostatic Devices.
Based on access, the market has been segmented into femoral access and radial access.
Based on procedures, the market has been segmented into interventional cardiology and interventional radiology/vascular surgery.
North America accounted for the largest share of Vascular Closure devices market. The large share is ascribed by sophisticated infrastructure, increasing prevalence of cardiovascular diseases and presence of leading players of this market in this region.